Long-Acting Injectables Market Size (USD 33952.09 M) by 2032 By Types (Small and Middle Sized Molecule, Large Sized Molecule) , Applications (Schizophrenia, Others) and Regional Forecast to 2032

Detailed TOC of Global Long-Acting Injectables Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Table of Content

1. Market Definition and Statistical Scope
1.1 Objective of the Study
1.2 Long-Acting Injectables Market Definition
1.3 Market Scope
1.3.1 Market Segmentation by Type, Downstream Industry and Marketing Channel
1.3.2 Major Geographies Covered (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
1.4 Years Considered for the Study (2018-2029)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2. Research Findings and Conclusion

3 Key Companies’ Profile
3.1 Competitive Profile
3.1.1 Global Long-Acting Injectables Sales and Market Share by Companies
3.1.2 Global Long-Acting Injectables Revenue and Market Share by Companies
3.2 Pfizer
3.2.1 Brief Introduction of Pfizer
3.2.2 Pfizer Sales, Growth Rate and Global Market Share from 2018-2023
3.2.3 Pfizer Related Products/Service Introduction
3.2.4 Pfizer Business Overview/Recent Development/Acquisitions
3.3 Eli Lilly
3.3.1 Brief Introduction of Eli Lilly
3.3.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2018-2023
3.3.3 Eli Lilly Related Products/Service Introduction
3.3.4 Eli Lilly Business Overview/Recent Development/Acquisitions
3.4 Otsuka
3.4.1 Brief Introduction of Otsuka
3.4.2 Otsuka Sales, Growth Rate and Global Market Share from 2018-2023
3.4.3 Otsuka Related Products/Service Introduction
3.4.4 Otsuka Business Overview/Recent Development/Acquisitions
3.5 Johnson & Johnson
3.5.1 Brief Introduction of Johnson & Johnson
3.5.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2018-2023
3.5.3 Johnson & Johnson Related Products/Service Introduction
3.5.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
3.6 GlaxoSmithKline
3.6.1 Brief Introduction of GlaxoSmithKline
3.6.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2018-2023
3.6.3 GlaxoSmithKline Related Products/Service Introduction
3.6.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
3.7 Alkermes
3.7.1 Brief Introduction of Alkermes
3.7.2 Alkermes Sales, Growth Rate and Global Market Share from 2018-2023
3.7.3 Alkermes Related Products/Service Introduction
3.7.4 Alkermes Business Overview/Recent Development/Acquisitions
3.8 Sanofi
3.8.1 Brief Introduction of Sanofi
3.8.2 Sanofi Sales, Growth Rate and Global Market Share from 2018-2023
3.8.3 Sanofi Related Products/Service Introduction
3.8.4 Sanofi Business Overview/Recent Development/Acquisitions

4. Global Long-Acting Injectables Market Segmented by Type
4.1 Global Long-Acting Injectables Sales, Revenue and Growth Rate by Type 2018-2023
4.2 Small and Middle Sized Molecule
4.3 Large Sized Molecule

5 Global Long-Acting Injectables Market Segmented by Downstream Industry
5.1 Global Long-Acting Injectables Sales, Revenue and Growth Rate by Downstream Industry 2018-2023
5.2 Schizophrenia
5.3 Others

6 Long-Acting Injectables Industry Chain Analysis
6.1 Value Chain Status
6.2 Upstream Raw Material Analysis
6.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
6.4 Distributors/Traders
6.5 Downstream Major Customer Analysis (by Region)
6.6 Value Chain Under Regional Conflicts

7. The Development and Dynamics of Long-Acting Injectables Market
7.1 Driving Factors of the Market
7.2 Factors Challenging the Market
7.3 Opportunities of the Global Long-Acting Injectables Market (Regions, Growing/Emerging Downstream Market Analysis)
7.4 Technology Status and Developments in the Long-Acting Injectables Market
7.5 Industry News
7.6 Market Investment Scenario Strategic Recommendations
7.7 COVID-19 Impact on Long-Acting Injectables Industry
7.7.1 Long-Acting Injectables Business Impact Assessment - Covid-19
7.7.2 Supply Chain Challenges
7.7.3 Market Trends and Potential Opportunities of Long-Acting Injectables in the COVID-19 Landscape
7.8 Industry SWOT Analysis

8 Global Long-Acting Injectables Market Segmented by Geography
8.1 Global Long-Acting Injectables Revenue and Market Share by Region 2018-2023
8.2 Global Long-Acting Injectables Sales and Market Share by Region 2018-2023

9 North America
9.1 North America Long-Acting Injectables Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2018-2023
9.2 North America Long-Acting Injectables Sales Analysis from 2018-2023
9.3 North America Long-Acting Injectables Import and Export from 2018-2023
9.4 North America Long-Acting Injectables Market by Country
9.4.1 North America Long-Acting Injectables Sales by Country (2018-2023)
9.4.2 North America Long-Acting Injectables Revenue by Country (2018-2023)
9.4.3 United States Long-Acting Injectables Sales and Growth (2018-2023)
9.4.4 Canada Long-Acting Injectables Sales and Growth (2018-2023)

10 Europe
10.1 Europe Long-Acting Injectables Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2018-2023
10.2 Europe Long-Acting Injectables Sales Analysis from 2018-2023
10.3 Europe Long-Acting Injectables Import and Export from 2018-2023
10.4 Europe Long-Acting Injectables Market by Country
10.4.1 Europe Long-Acting Injectables Sales by Country (2018-2023)
10.4.2 Europe Long-Acting Injectables Revenue by Country (2018-2023)
10.4.3 Germany Long-Acting Injectables Sales and Growth (2018-2023)
10.4.4 UK Long-Acting Injectables Sales and Growth (2018-2023)
10.4.5 France Long-Acting Injectables Sales and Growth (2018-2023)
10.4.6 Italy Long-Acting Injectables Sales and Growth (2018-2023)
10.4.7 Spain Long-Acting Injectables Sales and Growth (2018-2023)
10.4.8 Russia Long-Acting Injectables Sales and Growth (2018-2023)
10.4.9 Netherlands Long-Acting Injectables Sales and Growth (2018-2023)
10.4.10 Turkey Long-Acting Injectables Sales and Growth (2018-2023)
10.4.11 Switzerland Long-Acting Injectables Sales and Growth (2018-2023)
10.4.12 Sweden Long-Acting Injectables Sales and Growth (2018-2023)

11 Asia Pacific
11.1 Asia Pacific Long-Acting Injectables Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2018-2023
11.2 Asia Pacific Long-Acting Injectables Sales Analysis from 2018-2023
11.3 Asia Pacific Long-Acting Injectables Import and Export from 2018-2023
11.4 Asia Pacific Long-Acting Injectables Market by Country
11.4.1 Asia Pacific Long-Acting Injectables Sales by Country (2018-2023)
11.4.2 Asia Pacific Long-Acting Injectables Revenue by Country (2018-2023)
11.4.3 China Long-Acting Injectables Sales and Growth (2018-2023)
11.4.4 Japan Long-Acting Injectables Sales and Growth (2018-2023)
11.4.5 South Korea Long-Acting Injectables Sales and Growth (2018-2023)
11.4.6 Australia Long-Acting Injectables Sales and Growth (2018-2023)
11.4.7 India Long-Acting Injectables Sales and Growth (2018-2023)
11.4.8 Indonesia Long-Acting Injectables Sales and Growth (2018-2023)
11.4.9 Philippines Long-Acting Injectables Sales and Growth (2018-2023)
11.4.10 Malaysia Long-Acting Injectables Sales and Growth (2018-2023)

12 Latin America
12.1 Latin America Long-Acting Injectables Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2018-2023
12.2 Latin America Long-Acting Injectables Sales Analysis from 2018-2023
12.3 Latin America Long-Acting Injectables Import and Export from 2018-2023
12.4 Latin America Long-Acting Injectables Market by Country
12.4.1 Latin America Long-Acting Injectables Sales by Country (2018-2023)
12.4.2 Latin America Long-Acting Injectables Revenue by Country (2018-2023)
12.4.3 Brazil Long-Acting Injectables Sales and Growth (2018-2023)
12.4.4 Mexico Long-Acting Injectables Sales and Growth (2018-2023)
12.4.5 Argentina Long-Acting Injectables Sales and Growth (2018-2023)

13 Middle East & Africa
13.1 Middle East & Africa Long-Acting Injectables Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2018-2023
13.2 Middle East & Africa Long-Acting Injectables Sales Analysis from 2018-2023
13.3 Middle East & Africa Long-Acting Injectables Import and Export from 2018-2023
13.4 Middle East & Africa Long-Acting Injectables Market by Country
13.4.1 Middle East & Africa Long-Acting Injectables Sales by Country (2018-2023)
13.4.2 Middle East & Africa Long-Acting Injectables Revenue by Country (2018-2023)
13.4.3 Saudi Arabia Long-Acting Injectables Sales and Growth (2018-2023)
13.4.4 UAE Long-Acting Injectables Sales and Growth (2018-2023)
13.4.5 Egypt Long-Acting Injectables Sales and Growth (2018-2023)
13.4.6 South Africa Long-Acting Injectables Sales and Growth (2018-2023)

14. Global Long-Acting Injectables Market Forecast by Geography, Type, and Downstream Industry 2023-2029
14.1 Forecast of the Global Long-Acting Injectables Market from 2023-2029 by Region
14.2 Global Long-Acting Injectables Sales and Growth Rate Forecast by Type (2023-2029)
14.3 Global Long-Acting Injectables Sales and Growth Rate Forecast by Downstream Industry (2023-2029)
14.4 Long-Acting Injectables Market Forecast Under COVID-19

15 Appendix
15.1 Methodology
15.2 Research Data Source